Madison El-Saadi
Stock Analyst at B. Riley Securities
(4.51)
# 309
Out of 5,241 analysts
16
Total ratings
68.75%
Success rate
24.85%
Average return
Main Sectors:
Stocks Rated by Madison El-Saadi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMPS COMPASS Pathways | Initiates: Buy | $17 | $10.07 | +68.82% | 1 | Apr 24, 2026 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $26 → $31 | $32.89 | -5.75% | 4 | Mar 20, 2026 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $50 → $63 | $26.92 | +134.03% | 3 | Mar 13, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $61 → $101 | $73.18 | +38.02% | 1 | Jan 22, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintains: Buy | $11 → $14 | $5.99 | +133.72% | 2 | Dec 31, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $19 → $37 | $6.14 | +502.61% | 4 | Dec 12, 2025 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $179 | $226.67 | -21.03% | 1 | Oct 1, 2025 |
COMPASS Pathways
Apr 24, 2026
Initiates: Buy
Price Target: $17
Current: $10.07
Upside: +68.82%
Eton Pharmaceuticals
Mar 20, 2026
Maintains: Buy
Price Target: $26 → $31
Current: $32.89
Upside: -5.75%
Capricor Therapeutics
Mar 13, 2026
Maintains: Buy
Price Target: $50 → $63
Current: $26.92
Upside: +134.03%
Arrowhead Pharmaceuticals
Jan 22, 2026
Maintains: Buy
Price Target: $61 → $101
Current: $73.18
Upside: +38.02%
Vanda Pharmaceuticals
Dec 31, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $5.99
Upside: +133.72%
Wave Life Sciences
Dec 12, 2025
Maintains: Buy
Price Target: $19 → $37
Current: $6.14
Upside: +502.61%
Axsome Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $179
Current: $226.67
Upside: -21.03%